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INTRODUCTION
Both epistaxis and hypertension are common in the
general population. Though the data from nation-
wide survey showed that 10-15% of Nigerians are
hypertensive , recently emerging reports suggest the
prevalence rates of hypertension may be between 20
and 25% in this population . Populationbased data
on epistaxis are rare. A hospitalbased study from the
middle belt region of Nigeria nonetheless shows that
it constitutes 1.9% and 46.5% of total
otorhinolaryngologic patient load and nasal
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with epistaxis range from 17-67% . Whether there is
an association or cause and effect relationship
between epistaxis and hypertension is a subject of
longstanding controversy. While some workers have
reported an association between the two conditions ,
others did not . There is paucity of data addressing
this subject in Nigeria. This study aimed at
determining the prevalence of hypertension among
epistaxics, and the relationship between epistaxis and
hypertension.
The records of 73 adults aged 18 years and above who
were hospitalised between January 1995 and May
2006 on account of epistaxis in the emergency units
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Both epistaxis and hypertension are common in the general population.
This study aimed at determining the prevalence of hypertension among epistaxics, and the
relationship between epistaxis and hypertension.
Retrospective analysis of 62 adults comprising 31 each of males and females with a mean age of
41.4 ± 16.6 years (range: 18-90 years) that presented in the emergency units of two tertiary health institutions
seen over 11 years was done. Main outcome measure was the prevalence of hypertension amongst epistaxics.
Seventy-six age and sex-matched patients with bleeding from sites other than the nostrils with no record of
epistaxis were selected by simple random sampling as controls.
Peak prevalence of epistaxis occurred during the months of January and March. Compared to the
controls, the epistaxics had significantly higher blood pressures: (146.1 ± 40.7 mmHg versus 123.2 ± 16.3
mmHg systolic, P =0.001), and (91.3 ± 24.8 mmHg versus 78.2 ± 12.8 mmHg diastolic, P=0.001), and higher
proportions of patients with previous history of hypertension (32.3% versus 7.9%; p<0.001) and family history
of hypertension (12.9% versus 2.6%; p<0.02)..The proportion of subjects with blood pressure elevation at
presentation that remained sustained was significantly higher among the epistaxics than the nonepistaxics
(87.5% versus 47.6%, =8.1, P=0.005). The epistaxics had significantly higher prevalence of hypertension
than the non-epistaxics (45.2% versus 13.2%, =17.5, p=0.001). Univariate analysis demonstrated
association between epistaxis and hypertension (OR=5.4, 95% CI=2.4-12.5, P=0.001), and between epistaxis
and age (OR=0.9, 95% CI=1.3-12.5, P=0.02). On multivariate analysis using logistic regression the
association between epistaxis and hypertension persisted, after adjusting for age, sex, season and causes of
epistaxis (OR=5.6, 95% CI=1.7-15.6, P=0.01).
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(Usmanu Danfodiyo University Teaching Hospital,
and University of Ilorin Teaching Hospital, located
in Sokoto, Northern Nigeria and Ilorin, middle belt
of Nigeria, respectively) were retrieved. Data
collected included age, sex, occupation, and causes,
duration and month of presentation with epistaxis,
history and family history of hypertension, blood
pressure levels and antihypertensive medications.
Eleven patients with incomplete data were excluded
from the study. All patients with epistaxis and/or
hypertension had been seen by the investigating
Physician or Otorhinolaryngologist as applicable.
Epistaxis was defined as bleeding from the nostril.
The diagnosis of hypertension was made on the basis
of blood pressures = 140 mmHg systolic and/or = 90
mmHg diastolic or use of antihypertensive
medications . Patients without history of
hypertension whose blood pressures were elevated
on admis s ion bu t no rma l i s ed wi tho u t
antihypertensive medication during the period of
hospital stay were not considered as hypertensives.
Seasons were defined as follows: (Harmattan:
November - February, Hot: MarchMay and Rainy
seasons: JuneOctober).
Patients who were hospitalised in the emergency
unit during the same period with bleeding from sites
other than the nostril and with no record of history of
epistaxis were selected by simple random sampling
as controls. The sites of injury and bleeding in these
9
patients included head and neck, 39 (51.3%), upper
Limb, 8 (10.5%), lower limb, 13 (17.1%), trunk, 3
(4.0%), mouth, 2 (2.6%), ear, 1 (1.3%) and multiple
sites 10 (13.2%).
Data entry and analysis was done using SPSS
software. Continuous and categorical variables are
presented as mean plus or minus standard deviation
and percentages, respectively. Mean values between
two groups were compared using independent ttest
(2-tailed). The means between three or more groups
were compared using analysis of variance (ANOVA).
Chi square test and Fisher Exact test, where
appropriate, were utilised in comparing proportions.
The relationship between epistaxis and hypertension
was determined using univariate and multivariate
analysis. A pvalue < 0.05 was considered statistically
significant.
The characteristics of patients with epistaxis and
controls are shown in Table 1. The diseases identified
among the epistaxics are shown in Table 2. Some
patients had more than one conditions. Peak
prevalence of epistaxis occurred during the months of
January and March. Blood pressure ranged from
100160 mmHg systolic and 60100 mmHg diastolic








N (%) N (%)
Sex: Male 31 (50.0) 40 (52.6) 0.8
Female 31 (50.0) 36 (47.4)
Place of domicile: Urban 37 (59.7) 38 (50.0) 0.3
Rural 25 (40.3) 38 (50.0)
Tribe: Hausa and Fulani 44 (69.4) 59 (7.6) 0.5
Ibo 6 (9.6) 5 (6.6)
Yoruba 4 (6.5) 6 (7.9)
Others 9 (4.5) 6 (7.9)
Socioeconomic status: Upper 7 (11.3) 9 (11.8) 0.5
Middle 13 (21.0) 22 (29.0)
Lower 42 (67.6) 45 (59.2)
Season : Harmattan 27 (43.5) 18 (23.7) 0.02
Hot 22 (35.5) 30 (39.5)
Rain 13 (21.0) 28 (36.8)
Previous history of hypertension 20 (32.3) 6 (7.9) <0.001
Family history of hypertension 8 (12.9) 2 (2.6) 0.02
Elevated blood pressure on
presentation
32 (51.6) 21 (27.6)
0.004
Sustained hypertension 28 (45.2) 10 (27.6) <0.001
Mean ± SD Mean ± SD
Age (years) 41.4 ± 16.6 39.6 ± 12.6 0.4
Systolic blood pressure (mmHg) 146.1 ± 40.7 123.2 ± 16.3 <0.001
Diastolic blood pressure (mmHg) 91.3 ± 24.8 78.2 ± 12.8 <0.001






Model 1 adjusted for age
Model 2 adjusted for sex
Model 3 adjusted for season
Model 4 adjusted for causes of epistaxis
systolic and 60100 mmHg diastolic in the non-
epistaxic group. Compared to the nonepistaxics,
patients with epistaxis had significantly higher
systolic blood pressure (146.1 ± 40.7 mmHg versus
123.2 ± 16.3 mmHg, t=4.5, P =0.001), and diastolic
Diseases Identified In Patients with
Epistaxis
Comparison of Hypertensive and
Normotensive Patients with Epistaxis
Multivariate Logistic Regression







Characteristic Hypertensive Normotensive p-value
epistaxic epistaxic
N = 28 N = 34
N (%) N (%)
Mean ± SD Mean ± SD
Sex: Male 11 (39.3) 20 (58.3) 0.1
Female 17 (60.2) 14 (41.2)
Place of domicile: Urban: 9 (57.1) 16 (52.9) 0.9
Rural 19 (42.9) 18 (47.1)
Socioeconomic status: Upper 4 (14.3) 3(8.8) 0.6
Middle 7 (25.0) 6(17.6)
Lower 17 (60.7) 25 (73.5)
Season: Harmattan 14 (50.0) 13 (38.2) 0.6
Hot 9 (32.1) 13 (38.2)
Rain 5 (17.9) 8 (23.5)
Previous epistaxis 11 (39.3) 15 (44.1) 0.04
Age (years) 46.3 ± 9.5 38.3 ± 9.2 0.08
Duration of epistaxis(days) 3.8 ± 4.0 2.9 ± 3.7 0.5
blood pressure (91.3 ± 24.8 mmHg versus 78.2 ± 12.8
mmHg, t= 4.2, P=0.001). Patients with epistaxis did
not however differ significantly during the
harmattan, hot and rainy seasons with respect to
blood pressure: systolic, (152.4 ± 46.3 mmHg versus
136.5 ± 27.0 mmHg versus 152.4 ± 36.2 mmHg,
F=0.8, P=0.5); diastolic, (94.8 ± 23.3 mmHg versus
86.0 ± 21.4 versus 92.5 ± 36.5 mmHg, F=0.7, P= 0.6).
Compared to the nonepistaxics, patients with
epistaxis had a significantly higher proportion of
subjects with blood pressure elevation at presentation
that remained sustained (87.5% versus 47.6%,
=8.1, P=0.005). Overall, the prevalence of
hypertension was significantly higher among
patients with epistaxis compared to those without
(45.2% versus 13.2%, =17.5, p=0.001). Of the 28
hypertensive epistaxis, 8 (28.6%) were previously
unaware of a diagnosis of hypertension. In the
previously known hypertensives, the duration of
diagnosis of hypertension ranged from 0.5 to 8 years.
Though there was a higher proportion of patients with
hypertension in the lower than the middle class
(75.5% versus 60.9%) the difference was not
s t a t i s t i c a l l y s i g n i f i c a n t ( = 1 . 9 ;
p=0.40).Hypertensive and normotensive with
epistaxis are compared in Table 3. Though the
hypertensive were older than the normotensive
epistaxis, the difference was statistically
insignificant (46.3 ± 9.5 versus 38.3 ± 9.2 years;
p=0.08). The normotensives had significantly higher
proportion of patients with previous history of
epistaxis compared to the hypertensive epistaxics
(44.1% versus 39.3%; p=0.04).
Univariate analysis demonstrated association
between epistaxis and hypertension (OR=5.4, 95%
CI = 2.4-12.5, P=0.001), season (OR=1.8, 95%
CI=1.1-2.9, P=0.01) and age (OR=0.9, 95% CI=1.3-
12.5, P=0.02). On multivariate analysis using logistic
regression (Table 4), the association between
epistaxis and hypertension persisted after adjusting
for age, sex, season and causes of epistaxis (OR=5.6,
95% CI=1.7-15.6, P=0.001).
The age, peak season of presentation and diseases
identified among patients with epistaxis in the current
report are similar to the findings in previously
reported studies . Patients with epistaxis are
more likely to present during the harmattan season
(NovemberMarch) in Nigeria partly because this
season is characterised by low temperature and low
humidity which may predispose individuals to
decreased nasal ciliary movement, mucosal
breakdown and nasal bleeding . In contrast to the
findings in the Japanese, we observed no seasonal
variation in blood pressure among epistaxics.
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DISCUSSION







Nasal and nasopharyngeal tumour 2 (3.1)
Renal failure 2 (3.1)
Bleeding disorder 1 (1.6)
Eclampsia 1 (1.6)









1 0.5 5.4 0.001 2.4-12.5
2 2.1 0.027 0.03 1.00-1.16
3 3.8 1.532 0.001 1.77-12.1
4 4.1 0.255 0.01 0.42-1.40
5 5.6 0.627 0.001 1.7-15.6
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related morbidities has however been documented in
Nigeria .
The prevalence of hypertension among epistaxics in
the current report is higher than the value of 17.4%
reported in the middle belt of Nigeria . This wide
difference may be due to the fact that the study
population in the latter was larger and made up of
both adult and paediatric population. Our findings
corroborate with some previous reports that
demonstrated association between epistaxis and
hypertension , but differ from others with contrary
observation . The difference in findings may, again
be partly a reflection of differences in the study
population. Most hospitalbased studies tend to
demonstrate an association between epistaxis and
hypertension, while population-based data do not .
One important limitation of populationbased studies
is the reliance of the diagnosis of epistaxis on
volunteered or recalled history of nose bleeding
which may be inaccurate.
Blood pressure elevation in patients with epistaxis
can not be fully explained by the anxiety associated
with bleeding. This is evidenced in the current report
by the significantly higher proportion of patients
with initial blood pressure elevation who developed
sustained hypertension among the epistaxics
compared to those with bleeding from other sites. In
a study of a Caucasian population, about 79% of
epistaxics with initial blood pressure elevation had
sustained hypertension . This is just a little below
the value of 88% obtained in the current report. The
aetiologic role of hypertension in epistaxis is not
certain. It is possible that hypertension causes
arteriolosclerotic nasal vascular changes that
predispose hypertensives to increased susceptibility
to epistaxis. Fundus examination of hypertensive
epistaxics has, for example, demonstrated high
prevalence of hypertensive retinal arteriolosclerosis,
which is an index of arteriolosclerotic changes in
other parts of the body . Similarly, an association
between duration of hypertension and left
ventricular hypertrophy and nasal artery
enlargement determined by rhinoscopy has been
described among hypertensives with history of
epistaxis .
In conclusion, our findings support an association
between epistaxis and hypertension in the study
population. Further studies are required to whether
there is a cause and effect relationship.
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